Beihai Gofar Chuanshan Biological Co., Ltd. / Fundamentals
Income statement
- Net revenue
€39.34M - Cost of goods sold
€29.59M - Gross profit
€9.75M - SG&A expenses
€6.81M - R&D expenses
€924.59K - EBITDA
-€8.29M - D&A
€380.08K - EBIT
-€8.74M - Interest expenses
€332.60K - EBT
-€8.84M - Tax expenses
-€20.51K - Net income
-€9.32M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€3.12M - Changes in working capital
-€1.71M - Operating cash flow
€1.36M - Capex
€1.24M - Other investing cash flow
€250.82K - Net investing cash flow
-€161.06K - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
-€446.16K - Net financing cash flow
-€446.16K - Foreign exchange effects
€0.00 - Net change in cash
-€340.73K - Cash at end of period
€13.80M - Free cash flow
€2.59M
Balance sheet
- Cash and cash equivalents
€15.26M - Cash and short-term investments
€15.26M - Total receivables
€32.13M - Inventory
€9.77M - Other current assets
€786.76K - Total current assets
€57.94M - Property, plant & equipment
€17.40M - Goodwill
€16.47M - Intangible assets
€3.20M - Long-term investments
€0.00 - Other non-current assets
€18.63M - Total non-current assets
€56.40M - Total assets
€114.34M - Accounts payable
€9.60M - Short-term debt
€113.58K - Other current liabilities
€5.59M - Total current liabilities
€15.97M - Long-term debt
€4.00M - Deferred tax liabilities
€232.63K - Other non-current liabilities
€0.00 - Total non-current liabilities
€4.24M - Total liabilities
€20.21M - Common stock
€62.37M - Retained earnings
-€67.04M - Other equity
€0.00 - Total equity
€94.13M - Total liabilities and shareholders' equity
€114.34M
Company information
- Market capitalization
€348.65M - Employees
453 - Enterprise Value
€2.94B
Company ratios
- Gross margin
-
24.8% Even with peer group: 22.9% - EBITDA margin
-
-21.1% Much worse than peer group: 8.1% - EBIT margin
-
-22.2% Much worse than peer group: 5.0% - EBT margin
-
-22.5% Much worse than peer group: 5.4% - Net margin
-
-23.7% Much worse than peer group: 4.0% - ROE
-
-9.9% Worse than peer group: 2.8% - ROA
-
-8.2% Worse than peer group: 1.7% - Asset turnover
-
34.4% Much worse than peer group: 61.4% - FCF margin
-
0.3% Better than peer group: -5.6% - FCF yield
0.0% - Efficiency ratio
121.1% - Net sales per employee
-
€86.84K - Net income per employee
-
-€20.58K